Stand by for Designer Pain Pills

From NewsMax/October 2008

In the not-too-distant future, the pain reliever you take may be fine-tuned to your body.

Dr. Dennis Patin, an associate professor of clinical anesthesiology at the University of Miami Medical School, says future pain medications will be tailored to work within the genetic roadmap of each person.

“We’ll use samples of blood or body tissue to identify how a person metabolizes a drug, and what medication . . . is precisely best for an individual,” he asserts. This approach, known as nanomedicine, also could make pain relief a more exact science. A nano particle is small enough to reach where other medicines can’t go. “If nanomedicine can deliver a medication directly to where it is needed, without going to other parts of the body, then drugs should be more effective and have fewer side effects,” Patin explains.

Patin says pain relievers could be based on marijuana-like substances called endocannabinoids. “There’s been a societal taboo against studying these compounds,” he says. “But there are naturally occurring receptors in the body for marijuana molecules.”

Comment from CLWS: Hello! . . . “Nanomedicine”? Homeopathy? “Identify how a person metabolizes a drug, and what medication is precisely best for an individual”? EAV/VEGA/BE-T-A? Wow, what a concept. Hmmm.

An Informational Release for Members
From THE BRIDGE Newsletter of OIRF
Published October 2008

© Copyright 2008, OIRF, BC Canada

Related Articles

  • Removing Gallstones Naturally

    THERAPY TIP Submitted by: Dr. Justin Morais, Singapore Dear Friends, I found the English written version! This is a useful piece of information that [...]

  • S-acetyl glutathione

    THERAPY TIP For this issue, some comments from Dr. Brian L. MacCoy, Idaho, USA Revue / Journal Title International journal of oncology   ISSN 1019-6439 [...]

  • May 2020 Update #1

    Sunday, 03 May 2020 Dear Colleagues and Friends, Now, it is time for all of us to speak up! I strongly urge all of [...]

  • Global Burden of Cancers

    POINTS OF INTEREST Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Catherine de Martel MD, Jacques Ferlay ME, [...]

Sign-up to receive updates sent straight to your inbox